REFERENCES
- Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284(1):G15–G26.
- Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg. 1998;5(4):402–408.
- Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18(8):891–902.
- Toledo-Pereyra LH, Simmons RL, Najarian JS. Protection of the ischemic liver by donor pretreatment before transplantation. Am J Surg. 1975;129(5):513–517.
- Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ischemia/reperfusion injury. J Surg Res. 2002;105(2): 248–258.
- Halliwell B, Gutteridge JM. Lipid peroxidation, oxygen radicals, cell damage, and antioxidant therapy. Lancet. 1984;1(8391):1396–1397.
- Arkadopoulos N, Nastos C, Kalimeris K, Iron chelation for amelioration of liver ischemia-reperfusion injury. Hemoglobin. 2010;34(3):265–277.
- Zhao ZS, Khan S, O'Brien PJ. Catecholic iron complexes as cytoprotective superoxide scavengers against hypoxia: reoxygenation injury in isolated hepatocytes. Biochem Pharmacol. 1998;56(7):825–830.
- Colletti LM, Remick DG, Campbell DA Jr. Desferal attenuates TNF release following hepatic ischemia/reperfusion. J Surg Res. 1994;57(4):447–453.
- Drugas GT, Paidas CN, Yahanda AM, Conjugated desferoxamine attenuates hepatic microvascular injury following ischemia/reperfusion. Circ Shock. 1991;34(2):278–283.
- Galaris D, Barbouti A, Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: the role of antioxidants and iron chelating compounds. Curr Pharm Des. 2006;12(23):2875–2890.
- Omar R, Nomikos I, Piccorelli G, Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation. Gut. 1989;30(4):510–514.
- Polat C, Tokyol C, Kahraman A, The effects of desferoxamine and quercetin on hepatic ischemia-reperfusion induced renal disturbance. Prostaglandins Leukot Essent Fatty Acids. 2006;74(6):379–383.
- Tokyol C, Yilmaz S, Kahraman A, The effects of desferoxamine and quercetin on liver injury induced by hepatic ischaemia-reperfusion in rats. Acta Chir Belg. 2006;106(1):68–72.
- Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89(4):1269–1339.
- Hickey KA, Rubanyi G, Paul RJ, Characterization of a coronary vasoconstrictor produced by cultured endothelial cells. Am J Physiol. 1985;248(5 Pt 1):C550–C556.
- Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res. 2008;147(1):153–159.
- Kanduc D, Mittelman A, Serpico R, Cell death: apoptosis versus necrosis (review). Int J Oncol. 2002;21(1):165–170.
- Lemasters JJ, Qian T, He L, Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal. 2002;4(5):769–781.
- Bartels-Stringer M, Verpalen JT, Wetzels JF, Iron chelation or anti-oxidants prevent renal cell damage in the rewarming phase after normoxic, but not hypoxic cold incubation. Cryobiology. 2007;54(3):258–264.
- Arkadopoulos N, Vlahakos D, Kostopanagiotou G, Iron chelation attenuates intracranial pressure and improves survival in a swine model of acute liver failure. Liver Transpl. 2008;14(8):1116–1124.
- Groenendaal F, Shadid M, McGowan JE, Effects of desferoxamine, a chelator of free iron, on NA(+), K(+)-ATPase activity of cortical brain cell membrane during early reperfusion after hypoxia-ischemia in newborn lambs. Pediatr Res. 2000;48(4):560–564.
- Dendorfer A, Heidbreder M, Hellwig-Bürgel T, Desferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med. 2005;38(1):117–124.
- Qayumi AK, Jamieson WR, Poostizadeh A, Comparison of new iron chelating agents in the prevention of ischemia/reperfusion injury: a swine model of heart-lung transplantation. J Invest Surg. 1992;5(2):115–127.
- Hiraishi H, Yajima N, Yamaguchi N, Antioxidant protection against oxidant-induced damage in cultured gastric mucosal cells. Gastroenterol Jpn. 1993;28 Suppl 5: 132–138.
- Fantini GA, Yoshioka T. Desferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol. 1993;264(6 Pt 2):H1953–H1959.
- Babbs CF. Role of iron ions in the genesis of reperfusion injury following successful cardiopulmonary resuscitation: preliminary data and a biochemical hypothesis. Ann Emerg Med. 1985;14(8):777–783.